These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38863935)

  • 1. Pathological characteristics of reoperated regrowing clinically nonfunctioning pituitary tumor cases in comparison with initial surgical cases.
    Ishida A; Inoshita N; Tanabe N; Takano K; Tanaka-Mizuno S; Kato M; Yoshimoto H; Shiramizu H; Matsuoka G; Yamada S
    Front Endocrinol (Lausanne); 2024; 15():1400671. PubMed ID: 38863935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraoperative high-field MRI for transsphenoidal reoperations of nonfunctioning pituitary adenoma.
    Berkmann S; Schlaffer S; Nimsky C; Fahlbusch R; Buchfelder M
    J Neurosurg; 2014 Nov; 121(5):1166-75. PubMed ID: 25127413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic endonasal approach for craniopharyngioma: the importance of the relationship between pituitary stalk and tumor.
    Dho YS; Kim YH; Se YB; Han DH; Kim JH; Park CK; Wang KC; Kim DG
    J Neurosurg; 2018 Sep; 129(3):611-619. PubMed ID: 28960155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endonasal endoscopic reoperation for residual or recurrent craniopharyngiomas.
    Dhandapani S; Singh H; Negm HM; Cohen S; Souweidane MM; Greenfield JP; Anand VK; Schwartz TH
    J Neurosurg; 2017 Feb; 126(2):418-430. PubMed ID: 27153172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reoperative endoscopic endonasal surgery for residual or recurrent pituitary adenomas.
    Negm HM; Al-Mahfoudh R; Pai M; Singh H; Cohen S; Dhandapani S; Anand VK; Schwartz TH
    J Neurosurg; 2017 Aug; 127(2):397-408. PubMed ID: 27791524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and outcomes of null-cell versus silent gonadotroph adenomas in a series of 1166 pituitary adenomas from a single institution.
    Haddad AF; Young JS; Oh T; Pereira MP; Joshi RS; Pereira KM; Osorio RC; Donohue KC; Peeran Z; Sudhir S; Jain S; Beniwal A; Chopra AS; Sandhu NS; Theodosopoulos PV; Kunwar S; El-Sayed IH; Gurrola J; Blevins LS; Aghi MK
    Neurosurg Focus; 2020 Jun; 48(6):E13. PubMed ID: 32480370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Importance of Long Term Follow Up After Endoscopic Pituitary Surgery: Durability of Results and Tumor Recurrence.
    Almeida JP; Tabasinejad R; Kalyvas A; Takami H; Mohan N; O'Halloran PJ; Sanchez MM; Velasquez C; Zadeh G; Gentili F
    Neurol India; 2020; 68(Supplement):S92-S100. PubMed ID: 32611898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological factors related to regrowth of vestibular schwannoma after incomplete resection.
    Fukuda M; Oishi M; Hiraishi T; Natsumeda M; Fujii Y
    J Neurosurg; 2011 May; 114(5):1224-31. PubMed ID: 21214329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic versus non-cystic silent corticotrophic adenomas: clinical and histological analysis of 62 cases after microscopic transsphenoidal surgery-a retrospective, single-center study.
    Sumislawski P; Huckhagel T; Krajewski KL; Aberle J; Saeger W; Flitsch J; Rotermund R
    Sci Rep; 2023 Feb; 13(1):2468. PubMed ID: 36774403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating Methylome and Transcriptome Signatures Expands the Molecular Classification of the Pituitary Tumors.
    Silva-Júnior RMPD; Bueno AC; Martins CS; Coelli-Lacchini F; Ozaki JGO; Almeida-E-Silva DC; Marrero-Gutiérrez J; Santos ACD; Garcia-Peral C; Machado HR; Santos MVD; Elias PL; Moreira AC; Colli LM; Vêncio RZN; Antonini SR; de Castro M
    J Clin Endocrinol Metab; 2023 May; 108(6):1452-1463. PubMed ID: 36504388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile.
    Batista RL; Trarbach EB; Marques MD; Cescato VA; da Silva GO; Herkenhoff CGB; Cunha-Neto MB; Musolino NR
    World Neurosurg; 2018 Dec; 120():e241-e246. PubMed ID: 30138730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic outcomes of transsphenoidal surgery in pediatric patients with craniopharyngiomas: a single-center study.
    Yamada S; Fukuhara N; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Inoshita N; Ito J
    J Neurosurg Pediatr; 2018 Jun; 21(6):549-562. PubMed ID: 29600905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early versus late Gamma Knife radiosurgery following transsphenoidal surgery for nonfunctioning pituitary macroadenomas: a multicenter matched-cohort study.
    Pomeraniec IJ; Kano H; Xu Z; Nguyen B; Siddiqui ZA; Silva D; Sharma M; Radwan H; Cohen JA; Dallapiazza RF; Iorio-Morin C; Wolf A; Jane JA; Grills IS; Mathieu D; Kondziolka D; Lee CC; Wu CC; Cifarelli CP; Chytka T; Barnett GH; Lunsford LD; Sheehan JP
    J Neurosurg; 2018 Sep; 129(3):648-657. PubMed ID: 29076785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic Endonasal Approach to Giant Pituitary Adenomas: Surgical Outcomes and Review of the Literature.
    Rahimli T; Hidayetov T; Yusifli Z; Memmedzade H; Rajabov T; Aghayev K
    World Neurosurg; 2021 May; 149():e1043-e1055. PubMed ID: 33524611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposal of a clinically relevant working classification of pituitary neuroendocrine tumors based on pituitary transcription factors.
    Silva-Ortega S; García-Martinez A; Niveiro de Jaime M; Torregrosa ME; Abarca J; Monjas I; Picó Alfonso A; Aranda López I
    Hum Pathol; 2021 Apr; 110():20-30. PubMed ID: 33321163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary surgery and volumetric assessment of extent of resection: a paradigm shift in the use of intraoperative magnetic resonance imaging.
    Serra C; Burkhardt JK; Esposito G; Bozinov O; Pangalu A; Valavanis A; Holzmann D; Schmid C; Regli L
    Neurosurg Focus; 2016 Mar; 40(3):E17. PubMed ID: 26926057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A silent follicle-stimulating hormone-producing pituitary adenoma in a teenage male.
    Tamiya H; Fukuhara N; Yoshida N; Suzuki H; Takeshita A; Inoshita N; Nishioka H; Takeuchi Y; Sano T; Yamada S
    Endocr Pathol; 2011 Dec; 22(4):212-7. PubMed ID: 21853289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
    Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
    J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonfunctioning pituitary adenomas: association of Ki-67 and HMGA-1 labeling indices with residual tumor growth.
    Šteňo A; Bocko J; Rychlý B; Chorváth M; Celec P; Fabian M; Belan V; Šteňo J
    Acta Neurochir (Wien); 2014 Mar; 156(3):451-61; discussion 461. PubMed ID: 24452592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of T-box Transcription Factor in a Pituitary Adenoma Diagnostic Algorithm.
    McDonald WC; McDonald KN; Helmer JA; Ho B; Wang A; Banerji N
    Arch Pathol Lab Med; 2021 May; 145(5):592-598. PubMed ID: 32991684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.